Genmab — December 2012
-
de vil henvende sig actively
-
pay us big bucks til at få det på markedet
-
i partnerskab, i licens
-
men de kan først begynde på det igen
-
skal man så gentage de kliniske forsøg?
-
måske - måske ikke
-
du bliver nok nød til at lave non tox forsøg
-
måske skal du lave det fra scratch, men du har et 100 gange bedre molekyler
-
a number of details
-
a number of possibilities
-
nej vi kan sku ikke rumme det jan. lav nogle flere aftaler
-
hahaha - supercharging
-
ikke biobetter
-
en ny partner
-
ikke en eksisterende
-
det er et top10 pharma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind